Vmedvil5 Posted October 10, 2022 Report Posted October 10, 2022 It seems the NIH is backing a new engineered mechanosensitive channel-based gene therapy for glaucoma, read more at NIH backing first-in-class engineered mechanosensitive channel based gene therapy for glaucoma (ophthalmologytimes.com) Quote
Recommended Posts
Join the conversation
You can post now and register later. If you have an account, sign in now to post with your account.